Leerink Partners maintained a Market Perform rating on CVS Health (NYSE:CVS) shares while increasing the price target from ...

Evercore ISI has updated its outlook on CVS Health (NYSE:CVS) shares, raising the price target from $60.00 to $65.00 while ...

Check the time stamp on this data. Updated AI-Generated Signals for Cvs Health Corporation (CVS) available here: CVS. Type a ...

CVS faces significant 2025 headwinds, including intense pharmacy competition, threatened new federal government pressures, ...

Sen. James Lankford has been trying to pass legislation in response to an industry he believes will leave small towns without ...

OptumRx, the group's pharmacy benefit manager, along with its two main peers, Express Scripts and CVS Caremark Rx, have ...

FTC: ‘Big 3’ Pharmacy Benefit Managers Engaged in Price Gouging, PBMs, UnitedHealth OptumRx, CVS Caremark Rx, Express Scripts ...

The lawsuit claims that three major healthcare companies were pushing up the price of insulin by 1,200 percent.

The Federal Trade Commision (FTC) found prescription benefits managers like UnitedHealth's OptumRX have gained $7.3B from ...

From 2017 to 2022, the companies marked up prices at their pharmacies by hundreds or thousands of percent, netting them $7.3 billion in revenue.

On Tuesday, the Federal Trade Commission released its second interim staff report on prescription drug middlemen. The report ...